Benefit-risk balance of reoperation for persistent medullary thyroid cancer

Annals of Surgery

Volumn 257, Issue 4, 2013, Pages 751-757

  MaChens, Andreas ^a   Dralle, Henning ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

basal calcitonin; biochemical risk stratification; cervical reoperation; compartment oriented surgery; distant metastasis; lymph node metastasis; medullary thyroid carcinoma; postoperative hypoparathyroidism; recurrent laryngeal nerve palsy

Indexed keywords

CALCITONIN; GLUCONATE CALCIUM;

ADULT; ARTICLE; BIOCHEMISTRY; CALCITONIN BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HEALTH CARE FACILITY; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDULLARY CARCINOMA; MEDULLARY THYROID CANCER; PRIORITY JOURNAL; REOPERATION; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; TERTIARY HEALTH CARE; THYROID CANCER;

ADULT; CALCITONIN; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; REOPERATION; RISK ASSESSMENT; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84875214102     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31826bc239     Document Type: Article

References (20)

1. KouvarakiMA, Shapiro SE, FornageBD, et al.Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer. Surgery. 2003;134:946-955.
2. Cohen R, Campos JM, Salaun C, et al. Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d'Etudes des Tumeurs a Calcitonine (GETC). J Clin Endocrinol Metab. 2000;85:919-922.
3. Machens A, Dralle H. Biomarker-based risk stratification for previously untreated medullary thyroid cancer. J Clin Endocrinol Metab. 2010;95:2655-2663.
4. Yip DT, HassanM, Pazaitou-Panayiotou K, et al. Preoperative basal calcitonin and tumor stage correlate with postoperative calcitonin normalization in patients undergoing initial surgical management of medullary thyroid carcinoma. Surgery. 2011;150:1168-1177.
5. Ball DW. Guest Editorial: American Thyroid Association Guidelines for management of medullary thyroid cancer: an adult endocrinology perspective. Thyroid. 2009;6:547-550.
6. Machens A, Gimm O, Ukkat J, et al. Improved prediction of calcitonin normalization inmedullary thyroid carcinoma patients by quantitative lymph node analysis. Cancer. 2000;88:1909-1915.
7. Weber T, Schilling T, Frank-Raue K, et al. Impact of modified radical neck dissection on biochemical cure in medullary thyroid carcinomas. Surgery. 2001;130:1044-1049.
8. Scollo C, Baudin E, Travagli JP, et al. Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer. J Clin Endocrinol Metab. 2003;88:2070-2075.
9. Machens A, Schneyer U, Holzhausen HJ, et al. Prospects of remission in medullary thyroid carcinoma according to basal calcitonin level. J Clin Endocrinol Metab. 2005;90:2029-2034.
10. Bieglmayer C, Scheuba C, Niederle B, et al. Screening for medullary thyroid carcinoma: experience with different immunoassays for human calcitonin. Wien Klin Wochenschr. 2002;114:267-273.
11. Bieglmayer C, Vierhapper H, Dudczak R, et al. Measurement of calcitonin by immunoassay analysers. Clin Chem Med Lab. 2007;45:662-666.
12. Dralle H, Damm I, Scheumann GFW, et al. Compartment-oriented microdissection of regional lymph nodes in medullary thyroid carcinoma. Surg Today. 1994;24:112-121.
13. Dralle H. Lymph node dissection and medullary thyroid carcinoma. Br J Surg. 2002;89:1073-1075.
14. Dralle H. Malignant thyroid tumors [in German]. In: Garbe C, Albers P, Beckmann MW, et al., eds. Deutsche Krebsgesellschaft e.V. [Abbreviated interdisciplinary guidelines. Recommendations for diagnosis and therapy of malignant diseases]. Munich/Vienna/New York: W. Zuckschwerdt Verlag; 2006.
15. Hinze R, Holzhausen HJ, Gimm O, et al. Primary hereditary medullary thyroid carcinoma - C-cell morphology and correlation with preoperative calcitonin levels. Virchows Arch. 1998;433:203-208.
16. World Health Organisation. International Histological Classification of Tumours. 2nd ed. Berlin, Germany: Springer; 1988.
17. DeLellis RA, Lloyd RV, Heitz PU, et al., eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Endocrine Organs. Lyon, France: IARC Press; 2004.
18. Fleming JB, Lee JE, Bouvet M, et al. Surgical strategy for the treatment of medullary thyroid carcinoma. Ann Surg. 1999;230:697-707.
19. Moley JF, Dilley WG, DeBenedetti MK. Improved results of cervical reoperation for medullary thyroid carcinoma. Ann Surg. 1997;225:734-740; discussion 740-743.
20. Kebebew E, Kikuchi S, Duh QY, et al. Long-term results of reoperations and localization studies in patients with persistent or recurrent medullary thyroid cancer. Arch Surg 2000;135:895-901.